Reliable detection of rare mutations in EGFR gene codon L858 by PNA-LNA PCR clamp in non-small cell lung cancer

Advances in Experimental Medicine and Biology

Volumn 756, Issue , 2013, Pages 321-331

  Skronski, Michal ^a   Chorostowska Wynimko, Joanna ^a   Szczepulska, Ewa ^a   Szpechcinski, Adam ^a   Rudzinski, Piotr ^a   Orlowski, Tadeusz ^a   Langfort, Renata ^a  

^a NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

EGFR mutations; Non small cell lung cancer; PNA LNA PCR clamp; Rare mutations; Sequencing

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GENOMIC DNA; LOCKED NUCLEIC ACID; PEPTIDE NUCLEIC ACID;

CODON; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; EPIDERMAL GROWTH FACTOR RECEPTOR GENE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; MISSENSE MUTATION; MOLECULAR DIAGNOSIS; MOLECULAR DYNAMICS; ONCOGENE; PLEURA BIOPSY; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; WILD TYPE;

EID: 84867556644     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-94-007-4549-0_39     Document Type: Conference Paper

References (15)

1. Chen, C., Jiang, X. L., Zhan, C. C., & Li, K. (2011). Correlation of genes associated with drug response to prognosis of large cell lung carcinoma. Chinese Journal of Cancer, 30 , 497-504.
2. Chorostowska-Wynimko, J., & Szpechcinski, A. (2007). The impact of genetic markers on the diagnosis of lung cancer: A current perspective. Journal of Thoracic Oncology, 2 , 1044-1051.
3. Kancha, R. K., Peschel, C., & Duyster, J. (2011). The epidermal growth factor receptor-L861Q mutation increases kinase activity without leading to enhanced sensitivity toward epidermal growth factor receptor kinase inhibitors. Journal of Thoracic Oncology, 6 , 387-392.
4. Marchetti, A., Felicioni, L., & Buttitta, F. (2006). Assessing EGFR mutations. The New England Journal of Medicine, 354 (5), 526-528.
5. Molina-Vila, M. A., Bertran-Alamilo, J., Reguart, N., Taron, M., Castella, E., Ljatjos, M., Costa, C., Mayo, C., Pradas, A., QueralT, C., Botia, M., Perez-Cano, M., Carrasco, E., Tomas, M., Mate, J. L., Moran, T., & Rosell, R. (2008). A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cells. Journal of Thoracic Oncology, 5 , 1224-1235.
6. Nagai, Y., Miyazawa, H., Huqun, Tanaka, T., Udagawa, K., Kato, M., Fukuyama, S., Yokote, A., Kobayashi, K., Kanazawa, M., & Hagiwara, K. (2005). Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp. Cancer Research, 65 , 7276-7282.
7. Pirker, R., Herth, F. J., Kerr, K. M., Filipits, M., Taron, M., Gandara, D., Hirsch, F. R., Grunenwald, D., Popper, H., Smit, E., Dietel, M., Marchetti, A., Manegold, C., Schirmacher, P., Thomas, M., Rosell, R., Cappuzzo, F., & Stahel, R. (2010). Consensus for EGFR mutation testing in non-small cell lung cancer: Results from a European workshop. Journal of Thoracic Oncology, 5 , 1706-1713.
8. Prudkin, L., & Wistuba, I. I. (2006). Epidermal growth factor receptor abnormalities in lung cancer. Pathogenetic and clinical implications. Annals of Diagnostic Pathology, 10 , 306-315.
9. Sharma, S. V., Bell, D. W., Settleman, J., & Haber, D. A. (2007). Epidermal growth factor receptor mutations in lung cancer. Nature Reviews Cancer, 7 , 169-181.
10. Tam, I. Y., Chung, L. P., Suen, W. S., Wang, E., Wong, M. C., Ho, K. K., Lam, W. K., Chiu, S. W., Girard, L., Minna, J. D., Gazdar, A. F., & Wong, M. P. (2006). Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features. Clinical Cancer Research, 12 , 1647-1653.
11. Tanaka, T., Nagai, Y., Miyazawa, H., Koyama, N., Matsuoka, S., Sutani, A., Huqun Udagawa, K., Murayama, Y., Nagata, M., Shimizu, Y., Ikebuchi, K., KanazawA, M., Kobayashi, K., & Hagiwara, K. (2007). Reliability of the peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations integrated into the clinical practice for non-small cell lung cancers. Cancer Science, 98 , 246-252.
12. Tanaka, T., Matsuoka, M., Sutani, A., Gemma, A., Maemondo, M., Inoue, A., Okinaga, S., Nagashima, M., Oizumi, S., Uematsu, K., Nagai, Y., Moriyama, G., Miyazawa, H., Ikebuchi, K., Morita, S., Kobayashi, K., & Hagiwara, K. (2010). Frequency of and variables associated with the EGFR mutation and its subtypes. International Journal of Cancer, 126 , 651-655.
13. Williams, C., Ponten, F., Moberg, C., Söderkvist, P., Uhlen, M., Ponten, J., Sitbon, G., & Lundeberg, J. (1999). A high frequency of sequence alterations is due to formalin fi xation of archival specimens. American Journal of Pathology, 155 , 1467-1471.
14. Wu, S. G., Yang, C. H., Yu, C. J., Lee, J. H., Hsu, Y. C., Chang, Y. L., Shih, J. Y., & Yang, P. C. (2011). Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations. Lung Cancer, 72 , 333-339.
15. Zhang, G. C., Lin, J. Y., Wang, Z., Zhou, Q., Xu, C. R., Zhu, J. Q., Wang, K., Yang, X. N., Chen, G., Yang, J. J., Huang, Y. J., Liao, R. Q., & Wu, Y. L. (2007). Epidermal growth factor receptor double activating mutations involving both exons 19 and 21 exist in Chinese non-small cell lung cancer patients. Clinical Oncology (Royal College of Radiologists), 19 , 499-506.